Long reads
Building resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
Reaching a milestone
The decade-long process to register all chemicals used in Europe has concluded. Nina Notman takes stock of progress and looks to the next steps for chemical legislation in the region
Businesses use blockchain to take on trustlessness
Big companies are looking to blockchain technology to track transactions, finds Andy Extance, while upstarts exploit its cryptocurrency origins
Profiles
Rural power champion
Clementine Chambon is the 2018 Chemistry World Entrepreneur of the Year for her work using bioenergy to solve environmental, social and gender challenges in rural India
From chemist to patent attorney
How to make the career switch
The glue entrepreneurs
The business novices who launched global sticky success Sugru
Amplifying intelligent drug design
This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK
Opinion
The projects drug companies wish they’d never started
Failures are common in drug research, but some are bigger than others
Has Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
Living the lie
The mind of a serial fraudster must be an odd place indeed
Brute force and ignorance
It’s time for academia to get with the project plan and fail faster
More Business News
US approves first RNA interference drug
Alnylam’s Onpattro (patisiran) can treat a rare hereditary disease by silencing a specific gene
US government ordered to ban chlorpyrifos insecticide
Court gives EPA 60 days to finalise a ban, which was proposed under Obama but reversed by the Trump administration
Vaccine scandal and heart drug recall show China’s pharma struggles
Fifteen arrests amid evidence of bribery related to vaccines, despite new standards and penalties for fraud
Novartis exit from antibiotics a setback for race against resistance
Experts say business models must change to halt big pharma exodus
Trump coaxes big promises from big pharma
Several drug industry giants are now pledging to freeze price increases in the US, but some suggest the movement is a publicity stunt or worse
Drugmaker blocks Nevada execution
Alvogen obtains a restraining order to delay US prisoner’s execution, saying Nevada state obtained its sedative midazolam via ‘subterfuge’
US chemical safety agency wants Arkema disaster to spark real change
Industry guidance is needed to help hazardous chemical facilities better prepare for extreme weather events like flooding, the CSB warns
US sanctions threaten Iran–Europe petrochemical ties
US senators launch probe of Novartis’ payments to Trump lawyer
Takeda set to swallow Shire
Trump lays out plan to slash drug costs
Chemicals caught in the middle as tariffs loom
Deal protects world’s biggest selling drug from biosimilar erosion
India creates national drugs database to address supply and quality issues
Novartis’ $8.7bn AveXis deal shows gene therapy appeal
AkzoNobel sells off specialty chemicals arm in €10bn deal
US steel and aluminium tariffs threaten chemical and plastics sectors
